Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma  Tara A. Waterman, BA, Jeffrey A. Hagen,

Published byVebjørn Carlson Modified over 5 years ago

Similar presentations

Presentation on theme: "The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma  Tara A. Waterman, BA, Jeffrey A. Hagen,"— Presentation transcript:

1 The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma  Tara A. Waterman, BA, Jeffrey A. Hagen, MD, Jeffrey H. Peters, MD, Steven R. DeMeester, MD, Clive R. Taylor, MD, PhD, Tom R. DeMeester, MD  The Annals of Thoracic Surgery  Volume 78, Issue 4, Pages (October 2004) DOI: /j.athoracsur

2 Fig 1 Photomicrograph of an immunohistochemistry-stained slide showing individual tumor cells within the substance of the lymph node and a morphology consistent with cancer. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

3 Fig 2 Actuarial survival based on the presence or absence of lymph node metastases by hematoxylin & eosin examination (χ2 = 8.44; p = 0.004). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

4 Fig 3 Actuarial survival based on the extent of lymph node involvement, classified by the number of involved nodes (A) and the lymph node ratio (B) by hematoxylin & eosin (H&E) examination (χ2 = 30.8; p < and χ2 = 24.5; p < , respectively). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

5 Fig 4 Actuarial survival based on the presence or absence of lymph node metastases by immunohistochemistry (IHC) examination (χ2 = 0.48; p = 0.49). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

6 Fig 5 Actuarial survival in patients with limited lymph node involvement by hematoxylin & eosin (H&E) examination (ratio of involved nodes, < 10%) for patients with a combined node ratio of less than 10% and for a combined node ratio more than 10% (χ2 = 4.66; p = 0.03). (IHC = immunohistochemistry.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

7 Fig 6 Actuarial survival according to a proposed classification scheme based on hematoxylin & eosin (H&E) and immunohistochemistry (IHC) examination (χ2 = 27.3; p < ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

Download ppt "The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma  Tara A. Waterman, BA, Jeffrey A. Hagen,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Total Lymphadenectomy and Nodes-Based Prognostic Factors in Surgical Intervention for Esophageal Adenocarcinoma  Alberto Ruffato, MD, PhD, Marialuisa.

Total Lymphadenectomy and Nodes-Based Prognostic Factors in Surgical Intervention for Esophageal Adenocarcinoma  Alberto Ruffato, MD, PhD, Marialuisa.
Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S
Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma  Kimberly S. Grant, MD,

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma  Kimberly S. Grant, MD,
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the.

Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the.
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Esophagectomy Combined With Aortic Segment Replacement for Esophageal Cancer Invading the Aorta  Zhuangzhuang Cong, MD, Qiang Diao, MD, Jun Yi, MD, PhD,

Esophagectomy Combined With Aortic Segment Replacement for Esophageal Cancer Invading the Aorta  Zhuangzhuang Cong, MD, Qiang Diao, MD, Jun Yi, MD, PhD,
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy  John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,

Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy  John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy  John J. Nigro, MD, Jeffrey.

Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy  John J. Nigro, MD, Jeffrey.
Esophagectomy Combined With Aortic Segment Replacement for Esophageal Cancer Invading the Aorta  Zhuangzhuang Cong, MD, Qiang Diao, MD, Jun Yi, MD, PhD,

Esophagectomy Combined With Aortic Segment Replacement for Esophageal Cancer Invading the Aorta  Zhuangzhuang Cong, MD, Qiang Diao, MD, Jun Yi, MD, PhD,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Similar presentations

Ads by Google